Cabaletta Bio, Inc. — Director's Dealing 2019

Oct 25, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cabaletta Bio, Inc. (CABA)
CIK: 0001759138
Period of Report: 2019-10-24

Reporting Person: Marda Anup (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.23	2029-01-23	Common Stock (139282)		Direct

Footnotes

F1: This option vests over four years, with 25% vesting on January 22, 2020, and the remaining shares vesting in 12 equal quarterly installments thereafter.